Tropic Biosciences is a biotechnology company utilizing advanced plant breeding and gene editing technologies including CRISPR to develop commercial tropical crops. It focuses on commercialization of the company’s non-GMO coffee and bananas through greenhouse and field trials.
|Employees (est.) (Sept 2021)||90||(+3%)|
Tropic Biosciences total Funding
Tropic Biosciences latest funding size
Time since last funding
|a year ago|
Tropic Biosciences investors
|Temasek Holdings, Emerald Technology Ventures, Pontifax AgTech, Tekfen Ventures, Five Seasons Ventures, Bits x Bites, UK Innovation & Science Seed Fund, Genoa Ventures, Sumitomo Corporation Europe Limited, Skyviews Life Science|
|GBP||FY, 2017||FY, 2018|
When was Tropic Biosciences founded?
Tropic Biosciences was founded in 2016.
Who are Tropic Biosciences key executives?
Tropic Biosciences's key executives are Eyal Maori, Jean-Marie Graux and Gilad Gershon.
How many employees does Tropic Biosciences have?
Tropic Biosciences has 90 employees.
Who are Tropic Biosciences competitors?
Competitors of Tropic Biosciences include PreOmics, The Wave Talk and SEPPURE.
Where is Tropic Biosciences headquarters?
Tropic Biosciences headquarters is located at Norwich Research Park Innovation Centre, NR4 7GJ, Norfolk.
Where are Tropic Biosciences offices?
Tropic Biosciences has an office in Norfolk.
How many offices does Tropic Biosciences have?
Tropic Biosciences has 1 office.
Receive alerts for 300+ data fields across thousands of companies